United States Antimony Corporation stocks have been trading up by 8.33 percent amid bullish sentiment on antimony supply prospects.
Key Takeaways Traders Are Watching
- Management unveiled a flexible share repurchase plan of up to $100M, signaling they see UAMY’s current share price as too cheap and worth aggressively buying back.
- Q2 2026 revenue landed at $7.9M versus $21.7M expected, and full‑year guidance was cut roughly in half, even as EPS came in at breakeven instead of a projected loss.
- New mining assets in Alaska, Montana, and Ontario are ramping, with 2026 set to be the first year UAMY meaningfully feeds its own mined antimony into its smelters and Defense Logistics Agency contracts.
- Ore haulage at Stibnite Hill in Montana has more than doubled versus 2025, with about 576 tons of ~10% antimony ore moved since April as UAMY leans into domestic supply.
- The company secured $12.8M of U.S. Title III funding, raised about $49.1M in equity, doubled zeolite sales year over year, and launched a hydromet JV with Americas Gold and Silver to deepen its North American critical‑minerals footprint.
Live Update At 12:32:35 EDT: On Wednesday, September 02, 2026 United States Antimony Corporation stock [NYSE: UAMY] is trending up by 8.33%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
On the chart, United States Antimony Corporation (UAMY) is acting like a classic battleground name. After trading as high as the mid‑$6s in mid‑August, the stock has pulled back into the low‑$5s, with the latest close around $5.07. That’s a sharp slide from the August 11 spike near $6.58, but it still leaves UAMY well above early‑summer levels.
Recent intraday action shows tight, liquid trading between roughly $4.90 and $5.10, with a steady grind higher through the morning session. For short‑term traders, that intraday staircase from the high‑$4s into the low‑$5s signals dip‑buying and support building under $5.
More Breaking News
Fundamentally, UAMY is still unprofitable, with negative margins across the board, but revenue has grown over the last three and five years. The balance sheet is unusually strong for a micro‑cap miner: almost no debt, a current ratio above 11, and more than $40M in cash on the latest report. The flip side is valuation. A price‑to‑sales ratio around 20 means traders are paying up for the story, not the current earnings. That sets UAMY up as a momentum and catalyst trade more than a value play.
Why Traders Are Zeroed In On UAMY Right Now
What’s pulling so many eyes to UAMY is the clash between ugly near‑term numbers and aggressive long‑term moves.
On the negative side, United States Antimony’s Q2 2026 revenue was only $7.9M against $21.7M expected. Management also cut full‑year revenue guidance by roughly half. For any normal small‑cap, that kind of miss would be a disaster. Yet EPS printed at $0.00, better than the expected $0.02 loss, helped by non‑operating gains and tight cost control. That combination explains why the chart is volatile but not broken.
At the same time, UAMY is transforming its business. The company is ramping mining in Alaska, Montana’s Stibnite Hill, and Ontario’s Fostung area, expecting 2026 to be the first real year where its smelters run on its own ore. That matters because antimony supply has been dominated by China and Russia. If United States Antimony can feed its Defense Logistics Agency contracts with domestic ore, margins and strategic value both improve.
The Stibnite Hill update is a clear proof point. Since April, UAMY has hauled roughly 576 tons of high‑grade, ~10% antimony ore and more than doubled the daily pace versus 2025. That’s real, measurable progress, not just PowerPoint talk. Layer on the 110% year‑over‑year growth in the zeolite segment, and you’ve got a second leg of the story that is not tied directly to antimony prices.
Then comes the capital side. UAMY secured $12.8M in Title III funding, raised about $49.1M of equity, and still holds a large cash pile after funding capex. H.C. Wainwright cut its price target from $11.75 to $9.25 after Q2 but kept a Buy rating, signaling that while expectations were reset, the long‑term thesis remains alive for the Street.
The headline that really woke up traders, though, was the up‑to‑$100M buyback. United States Antimony authorized a flexible repurchase program with no end date, and the stock immediately traded higher in premarket. For a company with an enterprise value in the tens of millions, that’s a massive number. It tells traders management believes UAMY stock is seriously undervalued and is willing to shrink the float to prove it.
Add in a planned FOX Business “Mornings with Maria” appearance from the CEO and you’ve got a narrative catalyst that can pull in fresh retail volume. For short‑term momentum chasers, UAMY has all the ingredients: news flow, a strong chart base near $5, and a clear story around U.S. critical‑minerals security.
Conclusion
UAMY is not a widows‑and‑orphans name. United States Antimony is still losing money on an operating basis, margins are deep in the red, and management just slashed full‑year revenue guidance after a huge Q2 miss. That’s the cold reality buried under the headlines. Any trader ignoring that risk is playing blind.
But UAMY is also sitting on a rare setup. The balance sheet is clean, with lots of cash and almost no debt. Domestic mining at Stibnite Hill and other properties is finally ramping, giving the company a real shot at becoming a fully integrated North American antimony supplier to the U.S. government and commercial buyers. The zeolite segment’s 110% growth shows there is more to United States Antimony than one metal, and the hydromet JV with Americas Gold and Silver widens its processing footprint.
The up‑to‑$100M buyback is the loudest signal yet that management believes UAMY shares are mispriced. Analysts like H.C. Wainwright trimming their target but sticking with a positive rating back that up. For active traders, this is a classic “story stock” — one where execution, news, and price action matter more than current earnings.
As Tim Sykes likes to remind his students, “Patterns repeat, but only if you’re prepared and disciplined enough to trade them.” As millionaire penny stock trader and teacher Tim Sykes says, “Cut losses quickly, let profits ride, and don’t overtrade.” UAMY is giving the market a clear pattern: big volatility around real catalysts. The opportunity is there, but so is the risk. This breakdown is for educational and research purposes only, and every trader has to decide for themselves how to handle a name like UAMY.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:
Leave a reply